Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
In patients with hypertension who undergo elective PCI, the effects of long-term
administration of Calblock (azelnidipine) on plaque volume will be determined quantitatively
by 3D-IVUS and compared with those of amlodipine besilate (Norvasc or Amlodin).